China · Delayed Price · Currency is CNY Beijing SL Pharmaceutical Statistics
Total Valuation
SHE:002038 has a market cap or net worth of CNY 5.17 billion. The enterprise value is 4.08 billion.
| Market Cap | 5.17B |
| Enterprise Value | 4.08B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Jul 22, 2026 |
Share Statistics
SHE:002038 has 1.03 billion shares outstanding. The number of shares has decreased by -3.57% in one year.
| Current Share Class | 1.03B |
| Shares Outstanding | 1.03B |
| Shares Change (YoY) | -3.57% |
| Shares Change (QoQ) | +8.02% |
| Owned by Insiders (%) | 23.18% |
| Owned by Institutions (%) | 2.81% |
| Float | 629.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.30 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | 10.38 |
| P/OCF Ratio | 9.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.38, with an EV/FCF ratio of 8.20.
| EV / Earnings | n/a |
| EV / Sales | 7.35 |
| EV / EBITDA | 24.38 |
| EV / EBIT | n/a |
| EV / FCF | 8.20 |
Financial Position
The company has a current ratio of 7.04, with zero debt.
| Current Ratio | 7.04 |
| Quick Ratio | 5.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.96% and return on invested capital (ROIC) is -0.26%.
| Return on Equity (ROE) | -15.96% |
| Return on Assets (ROA) | -0.11% |
| Return on Invested Capital (ROIC) | -0.26% |
| Return on Capital Employed (ROCE) | -0.20% |
| Weighted Average Cost of Capital (WACC) | 4.10% |
| Revenue Per Employee | 616,694 |
| Profits Per Employee | -930,550 |
| Employee Count | 901 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.87 |
Taxes
| Income Tax | -9.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.01% in the last 52 weeks. The beta is -0.03, so SHE:002038's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -36.01% |
| 50-Day Moving Average | 5.50 |
| 200-Day Moving Average | 6.18 |
| Relative Strength Index (RSI) | 38.90 |
| Average Volume (20 Days) | 13,024,476 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002038 had revenue of CNY 555.64 million and -838.43 million in losses. Loss per share was -0.82.
| Revenue | 555.64M |
| Gross Profit | 329.46M |
| Operating Income | -9.72M |
| Pretax Income | -849.95M |
| Net Income | -838.43M |
| EBITDA | 167.41M |
| EBIT | -9.72M |
| Loss Per Share | -0.82 |
Balance Sheet
The company has 1.09 billion in cash and no debt, with a net cash position of 1.09 billion or 1.06 per share.
| Cash & Cash Equivalents | 1.09B |
| Total Debt | n/a |
| Net Cash | 1.09B |
| Net Cash Per Share | 1.06 |
| Equity (Book Value) | 4.83B |
| Book Value Per Share | 4.63 |
| Working Capital | 1.20B |
Cash Flow
In the last 12 months, operating cash flow was 554.72 million and capital expenditures -56.93 million, giving a free cash flow of 497.79 million.
| Operating Cash Flow | 554.72M |
| Capital Expenditures | -56.93M |
| Depreciation & Amortization | 177.13M |
| Net Borrowing | n/a |
| Free Cash Flow | 497.79M |
| FCF Per Share | 0.48 |
Margins
Gross margin is 59.29%, with operating and profit margins of -1.75% and -150.89%.
| Gross Margin | 59.29% |
| Operating Margin | -1.75% |
| Pretax Margin | -152.97% |
| Profit Margin | -150.89% |
| EBITDA Margin | 30.13% |
| EBIT Margin | -1.75% |
| FCF Margin | 89.59% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.20%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.20% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 2.06% |
| Buyback Yield | 3.57% |
| Shareholder Yield | 3.77% |
| Earnings Yield | -16.33% |
| FCF Yield | 9.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on July 4, 2019. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 4, 2019 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |